Literature DB >> 10566840

Relation between herpes simplex viruses and human immunodeficiency virus infections.

J L Severson1, S K Tyring.   

Abstract

The rates of herpes simplex virus (HSV) infection are rising, the highest prevalence being in the group infected with the human immunodeficiency virus (HIV). We review the relation between these 2 infections. The presence of genital ulcers increases the transmission of HIV, and the presence of HIV adversely affects the natural history of HSV infection. The detection and treatment of sexually transmitted diseases such as genital herpes actually decrease the rates of HIV infection in groups studied. The treatment of HSV in persons with HIV is challenging because the incidence of immunosuppression increases. Acyclovir resistance is more common in this group, but acyclovir use may prolong survival in some HIV-seropositive patients. Further studies are needed to determine whether persons with HIV disease should routinely be given HSV-specific therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566840     DOI: 10.1001/archderm.135.11.1393

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  8 in total

1.  Disposition kinetics of a dipeptide ester prodrug of acyclovir and its metabolites following intravenous and oral administrations in rat.

Authors:  Ravi S Talluri; Ripal Gaudana; Sudharshan Hariharan; Ritesh Jain; Ashim K Mitra
Journal:  Clin Res Regul Aff       Date:  2009-01-01

2.  Identifying anti-HSV compounds from unrelated plants using NMR and LC-MS metabolomic analysis.

Authors:  Gerhard Prinsloo; Jacques Vervoort
Journal:  Metabolomics       Date:  2018-09-28       Impact factor: 4.290

3.  Antiviral activity of recombinant cyanovirin-N against HSV-1.

Authors:  Hong Yu; Zong-tao Liu; Rui Lv; Wen-qing Zhang
Journal:  Virol Sin       Date:  2010-12-21       Impact factor: 4.327

4.  [Acyclovir-resistant herpes exulcerans et persistens. Type II].

Authors:  M Klammer; A Kuhn; T Ruzicka; H Stege
Journal:  Hautarzt       Date:  2003-03-07       Impact factor: 0.751

Review 5.  Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics.

Authors:  Thessicar E Antoine; Paul J Park; Deepak Shukla
Journal:  Rev Med Virol       Date:  2013-02-26       Impact factor: 6.989

6.  Herpes misdiagnosed as pyoderma gangrenosum.

Authors:  L Sorna Kumar; C Shanmugasekar; C Lakshmi; C R Srinivas
Journal:  Indian J Sex Transm Dis AIDS       Date:  2009-07

7.  Seroprevalence of Herpes Simplex Virus type-2 (HSV-2) among pregnant women who participated in a national HIV surveillance activity in Haiti.

Authors:  Jean Wysler Domercant; Frantz Jean Louis; Erin Hulland; Mark Griswold; Jocelyne Andre-Alboth; Tun Ye; Barbara J Marston
Journal:  BMC Infect Dis       Date:  2017-08-18       Impact factor: 3.090

8.  Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.

Authors:  Ajay Kesharwani; Suja Kizhiyedath Polachira; Reshmi Nair; Aakanksha Agarwal; Nripendra Nath Mishra; Satish Kumar Gupta
Journal:  BMC Complement Altern Med       Date:  2017-02-14       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.